Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

129 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
DNA repair gene expression and risk of locoregional relapse in breast cancer patients.
Le Scodan R, Cizeron-Clairac G, Fourme E, Meseure D, Vacher S, Spyratos F, de la Lande B, Cvitkovic F, Lidereau R, Bieche I. Le Scodan R, et al. Among authors: spyratos f. Int J Radiat Oncol Biol Phys. 2010 Oct 1;78(2):328-36. doi: 10.1016/j.ijrobp.2009.07.1735. Epub 2010 Jan 21. Int J Radiat Oncol Biol Phys. 2010. PMID: 20092964
Expression analysis of mitotic spindle checkpoint genes in breast carcinoma: role of NDC80/HEC1 in early breast tumorigenicity, and a two-gene signature for aneuploidy.
Bièche I, Vacher S, Lallemand F, Tozlu-Kara S, Bennani H, Beuzelin M, Driouch K, Rouleau E, Lerebours F, Ripoche H, Cizeron-Clairac G, Spyratos F, Lidereau R. Bièche I, et al. Among authors: spyratos f. Mol Cancer. 2011 Feb 27;10:23. doi: 10.1186/1476-4598-10-23. Mol Cancer. 2011. PMID: 21352579 Free PMC article.
PIK3R1 underexpression is an independent prognostic marker in breast cancer.
Cizkova M, Vacher S, Meseure D, Trassard M, Susini A, Mlcuchova D, Callens C, Rouleau E, Spyratos F, Lidereau R, Bièche I. Cizkova M, et al. Among authors: spyratos f. BMC Cancer. 2013 Nov 14;13:545. doi: 10.1186/1471-2407-13-545. BMC Cancer. 2013. PMID: 24229379 Free PMC article.
Profiling of EGFR mRNA and protein expression in 471 breast cancers compared with 10 normal tissues: a candidate biomarker to predict EGFR inhibitor effectiveness.
Meseure D, Vacher S, Drak Alsibai K, Trassard M, Susini A, Le Ray C, Lerebours F, Le Scodan R, Spyratos F, Marc Guinebretiere J, Lidereau R, Bieche I. Meseure D, et al. Among authors: spyratos f. Int J Cancer. 2012 Aug 15;131(4):1009-10. doi: 10.1002/ijc.26434. Epub 2011 Nov 30. Int J Cancer. 2012. PMID: 21918978 No abstract available.
COX2/PTGS2 Expression Is Predictive of Response to Neoadjuvant Celecoxib in HER2-negative Breast Cancer Patients.
DE Cremoux P, Hamy AS, Lehmann-Che J, Scott V, Sigal B, Mathieu MC, Bertheau P, Guinebretière JM, Pierga JY, Giacchetti S, Brain E, Marty M, Asselain B, Spyratos F, Bièche I. DE Cremoux P, et al. Among authors: spyratos f. Anticancer Res. 2018 Mar;38(3):1485-1490. doi: 10.21873/anticanres.12375. Anticancer Res. 2018. PMID: 29491076 Clinical Trial.
129 results